Israel - English - Ministry of Health

teva israel ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - emtrivir teva is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.emtrivir teva® is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.

Israel - English - Ministry of Health

teva israel ltd - diazepam - solution for injection - diazepam 10 mg / 2 ml - diazepam - symptomatic relief of tension and anxiety either alone or when associated with stressful situations. psychoneurotic states manifested by tension, anxiety, apprehension, fatique and depressive symptoms.in acute alcohol withdrawal, assival teva may be useful in the symptomatic relief of tremor, impending or acure delirium tremens and hallucinosis. assival teva is a useful adjunct in the relief of skeletal muscle spasms, spasticity, stiffman syndrome and tetanus. when used intravenously, assival teva injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures. as premedication in patients undergoing surgical procedures (the intramuscular route is preferred) or in patients undergoing cardioversion(when the intravenous route is preferred).

Israel - English - Ministry of Health

teva israel ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezomib teva is indicated for the treatment of patients with multiple myeloma. bortezomib teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine dr teva is indicated for:- the treatment of major depressive episodes. - the management of neuropathic pain associated with diabetic peripheral neuropathy. - the treatment of generalized anxiety disorder (gad).- the management of fibromyalgia. - the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low ‎back pain (clbp) and chronic pain due to osteoarthritis.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine dr teva is indicated for:- the treatment of major depressive episodes. - the management of neuropathic pain associated with diabetic peripheral neuropathy. - the treatment of generalized anxiety disorder (gad).- the management of fibromyalgia. - the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low ‎back pain (clbp) and chronic pain due to osteoarthritis.

Israel - English - Ministry of Health

teva israel ltd - deferasirox - tablets dispersible - deferasirox 125 mg - deferasirox - deferasirox teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). deferasirox teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).lic is the preferred method of iron overload determination and should be used wherever available.

Israel - English - Ministry of Health

teva israel ltd - deferasirox - tablets dispersible - deferasirox 250 mg - deferasirox - deferasirox teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). deferasirox teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).lic is the preferred method of iron overload determination and should be used wherever available.

Israel - English - Ministry of Health

teva israel ltd - deferasirox - tablets dispersible - deferasirox 500 mg - deferasirox - deferasirox teva is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over). deferasirox teva is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 μg /l).lic is the preferred method of iron overload determination and should be used wherever available.

Israel - English - Ministry of Health

teva israel ltd - teriflunomide - film coated tablets - teriflunomide 14 mg - teriflunomide - teriflunomide teva is indicated for the treatment of adult patients with relapsing remitting forms of multiple sclerosis (ms) to reduce the frequency of clinical relapses and to delay the progression of physical disability.

Israel - English - Ministry of Health

teva israel ltd - letrozole - tablets - letrozole 2.5 mg - letrozole - letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.